Forte Biosciences amends bylaws to update stockholder meeting procedures

Forte Biosciences, Inc.

Bylaws revised to require stockholder nominating directors to deliver evidence of Rule 14a-19 compliance at least 5 business days before meeting.
Changes conform to recent amendments to the Delaware General Corporation Law.
Amendments also include ministerial and clarifying revisions to align with current Delaware law.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Forte Biosciences, Inc.: Amended and restated bylaws to revise director nomination procedures, stockholder meeting procedures, and make ministerial changes to conform to Delaware law (effective 2023-02-07).

Change: bylaw amendment
Effective: 2023-02-07

Exact text from the filing

On February 7, 2023, the Board of Directors (the “Board”) of Forte Biosciences, Inc. (the “Company”), acting upon the recommendation of the Nominating and Corporate Governance Committee of the Board, amended and restated the Company’s amended and restated bylaws, effective immediately.

View on SEC.gov

Browse all governance changes →

Forte Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-030275

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.